Dr. Pavan Reddy Publishes in Early Breast Cancer Trial

Dr. Pavan Reddy has been recognized as an author in a JAMA Oncology, part of the American Medical Association, published trial that focused on clinical outcomes for women diagnosed with breast cancer and with a high recurrence score (RS) who received adjuvant chemotherapy plus endocrine therapy in a recent TAILORx trial.  This trial brought forth positive outcomes of freedom from recurrence of breast cancer at a distant site and freedom from recurrence, second primary cancer, and death.  This was conducted among 9,719 eligible women, with an average age of 56 years and recurrence scores of 26-100.  CCK is proud of our physician’s and their constant part in the ever-growing community of oncology research.  To read more about this study or to view the article in it’s entirety, see below.

  • Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy

    Published by JAMA Oncology - A Secondary Analysis of the TAILORx Randomized Clinical Trial